UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
phenylthiohydantoin - analogs & derivatives (373) 373
science & technology (365) 365
humans (362) 362
male (348) 348
life sciences & biomedicine (343) 343
phenylthiohydantoin - pharmacology (262) 262
prostate cancer (233) 233
oncology (194) 194
animals (186) 186
cell line, tumor (171) 171
prostatic neoplasms, castration-resistant - drug therapy (167) 167
receptors, androgen - metabolism (150) 150
phenylthiohydantoin - therapeutic use (133) 133
enzalutamide (120) 120
mice (116) 116
prostatic neoplasms - drug therapy (106) 106
prostatic neoplasms, castration-resistant - pathology (104) 104
receptors, androgen - genetics (104) 104
antineoplastic agents - pharmacology (95) 95
androgens (94) 94
androgen receptor (85) 85
prostatic neoplasms - pathology (84) 84
cancer (80) 80
cell proliferation - drug effects (78) 78
xenograft model antitumor assays (77) 77
pharmacology & pharmacy (74) 74
prostatic neoplasms, castration-resistant - metabolism (74) 74
cell biology (72) 72
prostate (70) 70
drug resistance, neoplasm (69) 69
androgen antagonists - pharmacology (68) 68
antineoplastic agents - therapeutic use (68) 68
prostatic neoplasms - metabolism (62) 62
signal transduction - drug effects (61) 61
tumors (61) 61
aged (59) 59
metastasis (59) 59
androgen receptor antagonists - pharmacology (57) 57
biochemistry & molecular biology (56) 56
castration (54) 54
prostatic neoplasms, castration-resistant - genetics (54) 54
prostatic neoplasms - genetics (51) 51
mice, nude (50) 50
drug resistance, neoplasm - drug effects (48) 48
biological and medical sciences (46) 46
gene expression regulation, neoplastic - drug effects (46) 46
middle aged (46) 46
treatment outcome (45) 45
urologic and male genital diseases (43) 43
cancer therapies (41) 41
neoplasm metastasis (41) 41
gene expression (40) 40
care and treatment (38) 38
phenylthiohydantoin - administration & dosage (38) 38
signal transduction (38) 38
androgen receptor antagonists - therapeutic use (36) 36
androgen antagonists - therapeutic use (35) 35
endocrinology & metabolism (35) 35
apoptosis - drug effects (33) 33
cell survival - drug effects (33) 33
drug resistance, neoplasm - genetics (33) 33
urology & nephrology (33) 33
abiraterone (32) 32
medical sciences (32) 32
mutation (32) 32
analysis (31) 31
castration-resistant prostate cancer (31) 31
chemotherapy (31) 31
drug resistance (31) 31
metastases (30) 30
aged, 80 and over (28) 28
androstenes - pharmacology (28) 28
androstenes - therapeutic use (28) 28
drug therapy (28) 28
research (28) 28
research paper (28) 28
xenografts (28) 28
anilides - pharmacology (27) 27
disease progression (27) 27
female (27) 27
development and progression (25) 25
gene expression regulation, neoplastic (24) 24
pharmacology (24) 24
pharmacology. drug treatments (24) 24
phenylthiohydantoin - adverse effects (24) 24
proteins (24) 24
receptors, androgen - chemistry (24) 24
amino acid sequence (23) 23
antineoplastic agents (23) 23
drug synergism (23) 23
nephrology. urinary tract diseases (23) 23
nitriles - pharmacology (23) 23
phenylthiohydantoin - chemistry (23) 23
receptors, androgen - drug effects (23) 23
tosyl compounds - pharmacology (23) 23
tumors of the urinary system (23) 23
urinary tract. prostate gland (23) 23
cell proliferation (22) 22
drug interactions (22) 22
adult (21) 21
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 5/2009, Volume 324, Issue 5928, pp. 787 - 790
COS cells | Androgens | Cell lines | Agonists | Oncology | Reports | Androgen antagonists | Prostate cancer | Heterologous transplantation | Tumors | Vehicles | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Chemotherapy | Pharmacology. Drug treatments | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Antineoplastic agents | Transcription, Genetic - drug effects | Nitriles - pharmacology | Phenylthiohydantoin - therapeutic use | Humans | Receptors, Androgen - metabolism | Biological Availability | Male | Antineoplastic Agents - therapeutic use | Tosyl Compounds - pharmacology | Antineoplastic Agents - metabolism | Cell Nucleus - metabolism | Receptors, Androgen - chemistry | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Prostatic Neoplasms - drug therapy | Androgen Antagonists - pharmacokinetics | Phenylthiohydantoin - pharmacology | Nitriles - metabolism | Prostatic Neoplasms - pathology | Androgen Antagonists - metabolism | Androgen Antagonists - pharmacology | Anilides - metabolism | DNA - metabolism | Phenylthiohydantoin - analogs & derivatives | Xenograft Model Antitumor Assays | Animals | Receptors, Androgen - genetics | Anilides - pharmacology | Tosyl Compounds - metabolism | Androgen Antagonists - therapeutic use | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Phenylthiohydantoin - metabolism | Drug Screening Assays, Antitumor | Phenylthiohydantoin - pharmacokinetics | Care and treatment | Antiandrogens | Dosage and administration | Drug therapy | Methods | Cancer | Pharmacology | Binding sites | Index Medicus
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 0027-8874, 11/2011, Volume 103, Issue 22, pp. 1665 - 1675
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Tumors | Cancer Vaccines - pharmacology | Humans | Male | Antineoplastic Agents - therapeutic use | Bevacizumab | Prostatic Neoplasms - immunology | RANK Ligand - pharmacology | Receptors, Androgen - drug effects | Treatment Failure | Prostatic Neoplasms - drug therapy | Phenylthiohydantoin - pharmacology | Tumor Microenvironment - drug effects | Dasatinib | Antibodies, Monoclonal - pharmacology | Angiogenesis Inhibitors - pharmacology | Clusterin - pharmacology | Pyrimidines - pharmacology | Denosumab | Prostate-Specific Antigen - blood | Orchiectomy | Signal Transduction - drug effects | Anilides - pharmacology | Mice | Receptor Cross-Talk - drug effects | Endothelin-1 - antagonists & inhibitors | Immunotherapy - methods | Taxoids - pharmacology | Ipilimumab | Tissue Extracts - pharmacology | Bone Remodeling - drug effects | Pyrrolidines - pharmacology | Antibodies, Monoclonal, Humanized - pharmacology | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Molecular Targeted Therapy - methods | Prostatic Neoplasms - pathology | Antineoplastic Agents, Hormonal - pharmacology | Androstenols - pharmacology | Androstenes | Clinical Trials as Topic | Mice, SCID | Phenylthiohydantoin - analogs & derivatives | Biomarkers, Tumor - blood | Xenograft Model Antitumor Assays | Cancer Vaccines - immunology | Pyrroles - pharmacology | Animals | RANK Ligand - antagonists & inhibitors | Pyridines - pharmacology | Thiazoles - pharmacology | Immune response | Development and progression | Cellular signal transduction | Research | Drug therapy | Health aspects | Prostate cancer | Risk factors | Metastasis | Cancer therapies | Index Medicus | Review
Journal Article
Journal Article
European urology, ISSN 0302-2838, 11/2018, Volume 74, Issue 5, pp. 562 - 572
Journal Article
CA: a cancer journal for clinicians, ISSN 0007-9235, 09/2012, Volume 62, Issue 5, pp. 299 - 308
Journal Article
Journal Article
Journal Article